Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 2Phase 3 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Classical hematology 1

Conditions

Nasopharyngeal Carcinoma 1Colonic Neoplasms 1Anemia, Iron-Deficiency 1Anemia 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Unknown × iron isomaltoside 1000 × Clear all
NCT05913414 2023-06-22

Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 2 Unknown
120 enrolled
Classical hematologyHead & Neck

Nasopharyngeal Carcinoma, Anemia, Anemia, Iron-Deficiency

NCT05299411 2022-03-29

Intravenous Iron Infusion on Chemotherapy-induced Anemia

Korea University Guro Hospital

Phase 2 Unknown
80 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡